(E)-4-(5-hydroxy-3-methylpent-3-en-1-yl)-8-(hydroxymethyl)-4a,8-dimethyl-3-methylenedecahydronaphthalen-1-yl benzoate

Catalog No. :
ACZVPP934
CAS No. :
130838-00-5
Molecular Formula :
C27H38O4
Molecular Weight :
426.60

IUPAC Name:(E)-4-(5-hydroxy-3-methylpent-3-en-1-yl)-8-(hydroxymethyl)-4a,8-dimethyl-3-methylenedecahydronaphthalen-1-yl benzoate

(E)-4-(5-hydroxy-3-methylpent-3-en-1-yl)-8-(hydroxymethyl)-4a,8-dimethyl-3-methylenedecahydronaphthalen-1-yl benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-4-(5-hydroxy-3-methylpent-3-en-1-yl)-8-(hydroxymethyl)-4a,8-dimethyl-3-methylenedecahydronaphthalen-1-yl benzoate
IUPAC Name(E)-4-(5-hydroxy-3-methylpent-3-en-1-yl)-8-(hydroxymethyl)-4a,8-dimethyl-3-methylenedecahydronaphthalen-1-yl benzoate
Molecular FormulaC27H38O4
Molecular Weight426.60
SMILESC=C1CC(OC(=O)C2=CC=CC=C2)C2C(C)(CO)CCCC2(C)C1CC/C(C)=C/CO
InChI KeyWGSYIFPPMZUQAN-CPNJWEJPSA-N
SynonymScoparil;Scoparinol;1-Naphthalenemethanol,8-(benzoyloxy)- decahydro-5-[(3E)-5-hydroxy-3-methyl-3- pentenyl]-1,4a-dimethyl-6-methylene-,(1R,- 4aR,5S,8R,8aR)-;1-Naphthalenemethanol, 8-(benzoyloxy)decahydro-5-[(3E)-5-hydroxy-3-methyl-3-penten-1-yl]-1,4a-dimethyl-6-methylene-, (1R,4aR,5S,8R,8aR)-
CAS No.130838-00-5

Synthetic Route by SureRoute

1. ACZVPP934 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZVPP934 route product structure diagram
    ACZVPP934130838-00-5
Inquiry

2. ACZVPP934 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZVPP934 route product structure diagram
    ACZVPP934130838-00-5
Inquiry

Comments (0)